Company intelligence / Profile preview

Aavis Pharmaceuticals

Hoschton, Georgia, USAaavispharmaceuticals.com ↗
Ownership
Private
Employees
~46
Development stage
Other
01

Overview

Aavis Pharmaceuticals is a USFDA-approved specialty pharmaceutical company focused on the contract development and manufacturing of complex oral solid generics. The company has more than 12 products commercially launched or filed with the USFDA. It specializes in advanced formulation technologies such as immediate/controlled/chrono/pulsatile/delayed-release systems for oral solids. In partnership with Jubilant Pharma Ltd., it has commercialized hydroxychloroquine sulfate tablets in the U.S. R&D efforts are ongoing to enhance existing formulations and develop new drug molecules for improved patient compliance.

Therapeutic areas
ImmunologyInfectious DiseasesOther
Modalities
Small moleculeOral solid dosage forms (immediate release, controlled release, sustained release, delayed release, pulsatile release, chrono release)
Industry
Biotech
02

Partnerships

Jubilant Pharma Ltd./Jubilant Cadista – distribution/commercialization partnership for hydroxychloroquine sulfate tablets in the U.S.Senores Pharmaceuticals Pvt. Ltd. – R&D partner/affiliate for product development and marketing in USA/rest of world markets

Beyond the preview

Go deeper on Aavis Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aavis Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call